{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:28:20Z","timestamp":1777404500335,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1012408","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000}}],"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["G-001522"],"award-info":[{"award-number":["G-001522"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C12077\/A26223"],"award-info":[{"award-number":["C12077\/A26223"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009795","name":"Pancreatic Cancer UK","doi-asserted-by":"publisher","award":["IRAS Number: 234637, NIHR Portfolio no. 7343"],"award-info":[{"award-number":["IRAS Number: 234637, NIHR Portfolio no. 7343"]}],"id":[{"id":"10.13039\/100009795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR HTA grant 16\/46\/01"],"award-info":[{"award-number":["NIHR HTA grant 16\/46\/01"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G9901012 and G0801228"],"award-info":[{"award-number":["G9901012 and G0801228"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1479\/A2884"],"award-info":[{"award-number":["C1479\/A2884"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Eve Appeal"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00004\/01"],"award-info":[{"award-number":["MC_UU_00004\/01"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C7690\/A26881"],"award-info":[{"award-number":["C7690\/A26881"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDPGM-May22\\100002"],"award-info":[{"award-number":["EDDPGM-May22\\100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Research UK and EPSRC","award":["EDDCPJT\/100022"],"award-info":[{"award-number":["EDDCPJT\/100022"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The grim (&lt;10% 5-year) survival rates for pancreatic ductal adenocarcinoma (PDAC) are attributed to its complex intrinsic biology and most often late-stage detection. The overlap of symptoms with benign gastrointestinal conditions in early stage further complicates timely detection. The suboptimal diagnostic performance of carbohydrate antigen (CA) 19\u20139 and elevation in benign hyperbilirubinaemia undermine its reliability, leaving a notable absence of accurate diagnostic biomarkers. Using a selected patient cohort with benign pancreatic and biliary tract conditions we aimed to develop a data analysis protocol leading to a biomarker signature capable of distinguishing patients with non-specific yet concerning clinical presentations, from those with PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>539 patient serum samples collected under the Accelerated Diagnosis of neuro Endocrine and Pancreatic TumourS (ADEPTS) study (benign disease controls and PDACs) and the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS, healthy controls) were screened using the Olink Oncology II panel, supplemented with five in-house markers. 16 specialized base-learner classifiers were stacked to select and enhance biomarker performances and robustness in blinded samples. Each base-learner was constructed through cross-validation and recursive feature elimination in a discovery set comprising approximately two thirds of the ADEPTS and UKCTOCS samples and contrasted specific diagnosis with PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The signature which was developed using diagnosis-specific ensemble learning demonstrated predictive capabilities outperforming CA19-9, the only biomarker currently accepted by the FDA and the National Comprehensive Cancer Network guidelines for pancreatic cancer, and other individual biomarkers and combinations in both discovery and held-out validation sets. An AUC of 0.98 (95% CI 0.98\u20130.99) and sensitivity of 0.99 (95% CI 0.98\u20131) at 90% specificity was achieved with the ensemble method, which was significantly larger than the AUC of 0.79 (95% CI 0.66\u20130.91) and sensitivity 0.67 (95% CI 0.50\u20130.83), also at 90% specificity, for CA19-9, in the discovery set (p = 0.0016 and p = 0.00050, respectively). During ensemble signature validation in the held-out set, an AUC of 0.95 (95% CI 0.91\u20130.99), sensitivity 0.86 (95% CI 0.68\u20131), was attained compared to an AUC of 0.80 (95% CI 0.66\u20130.93), sensitivity 0.65 (95% CI 0.48\u20130.56) at 90% specificity for CA19-9 alone (p = 0.0082 and p = 0.024, respectively). When validated only on the benign disease controls and PDACs collected from ADEPTS, the diagnostic-specific signature achieved an AUC of 0.96 (95% CI 0.92\u20130.99), sensitivity 0.82 (95% CI 0.64\u20130.95) at 90% specificity, which was still significantly higher than the performance for CA19-9 taken as a single predictor, AUC of 0.79 (95% CI 0.64\u20130.93) and sensitivity of 0.18 (95% CI 0.03\u20130.69) (p = 0.013 and p = 0.0055, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our ensemble modelling technique outperformed CA19-9, individual biomarkers and indices developed with prevailing algorithms in distinguishing patients with non-specific but concerning symptoms from those with PDAC, with implications for improving its early detection in individuals at risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pcbi.1012408","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T16:02:06Z","timestamp":1724947326000},"page":"e1012408","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection"],"prefix":"10.1371","volume":"20","author":[{"given":"Alexander","family":"Ney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-0649","authenticated-orcid":true,"given":"Nuno R.","family":"Nen\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Sedlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Acedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Blyuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J.","family":"Whitwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eithne","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Gentry-Maharaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-312X","authenticated-orcid":true,"given":"Norman R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-1732","authenticated-orcid":true,"given":"Usha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe K.","family":"Fusai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Zaikin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"pcbi.1012408.ref001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer.","volume":"388","author":"T Kamisawa","year":"2016","journal-title":"The Lancet"},{"key":"pcbi.1012408.ref002","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"H Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians."},{"key":"pcbi.1012408.ref003","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.annonc.2021.01.006","article-title":"European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer","volume":"32","author":"G Carioli","year":"2021","journal-title":"Annals of Oncology"},{"issue":"1","key":"pcbi.1012408.ref004","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001837","article-title":"Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM","volume":"266","author":"G Marchegiani","year":"2017","journal-title":"Annals of Surgery"},{"key":"pcbi.1012408.ref005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2018.11.014","article-title":"Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals.","volume":"19","author":"G Zerboni","year":"2019","journal-title":"Pancreatology"},{"key":"pcbi.1012408.ref006","article-title":"Early detection of pancreatic cancer","author":"SP Pereira","year":"2020","journal-title":"The Lancet Gastroenterology and Hepatology"},{"key":"pcbi.1012408.ref007","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.gastro.2020.03.088","article-title":"AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review","volume":"159","author":"HR Aslanian","year":"2020","journal-title":"Gastroenterology"},{"key":"pcbi.1012408.ref008","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for Pancreatic Cancer.","volume":"322","author":"DK Owens","year":"2019","journal-title":"JAMA"},{"key":"pcbi.1012408.ref009","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.gastro.2021.11.021","article-title":"Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis","volume":"162","author":"A Chhoda","year":"2022","journal-title":"Gastroenterology"},{"key":"pcbi.1012408.ref010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/gutjnl-2018-316027","article-title":"European evidence-based guidelines on pancreatic cystic neoplasms","volume":"67","year":"2018","journal-title":"Gut"},{"key":"pcbi.1012408.ref011","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2468-1253(16)30079-6","article-title":"Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study.","volume":"1","author":"FM Walter","year":"2016","journal-title":"The Lancet Gastroenterology & Hepatology."},{"key":"pcbi.1012408.ref012","doi-asserted-by":"crossref","first-page":"9849","DOI":"10.2147\/CMAR.S221427","article-title":"Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence.","volume":"11","author":"G Lukacs","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"11","key":"pcbi.1012408.ref013","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/gutjnl-2014-308653","article-title":"Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages","volume":"64","author":"J Yu","year":"2015","journal-title":"Gut"},{"issue":"2","key":"pcbi.1012408.ref014","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12029-016-9876-7","article-title":"Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography.","volume":"48","author":"SJ Ahn","year":"2017","journal-title":"J Gastrointest Cancer"},{"key":"pcbi.1012408.ref015","doi-asserted-by":"crossref","first-page":"g7400","DOI":"10.1136\/bmj.g7400","article-title":"Rethinking diagnostic delay in cancer: how difficult is the diagnosis?","volume":"349","author":"G Lyratzopoulos","year":"2014","journal-title":"BMJ"},{"key":"pcbi.1012408.ref016","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.annonc.2023.04.375","article-title":"P-319 Delay in pancreatic cancer diagnosis and treatment: Call to action","volume":"34","author":"S Escorza-Calzada","year":"2023","journal-title":"Annals of Oncology"},{"key":"pcbi.1012408.ref017","doi-asserted-by":"crossref","first-page":"e005720","DOI":"10.1136\/bmjopen-2014-005720","article-title":"A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer","volume":"4","author":"MG Keane","year":"2014","journal-title":"BMJ open"},{"key":"pcbi.1012408.ref018","doi-asserted-by":"crossref","first-page":"e836","DOI":"10.3399\/BJGP.2021.0153","article-title":"Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population","volume":"71","author":"W Liao","year":"2021","journal-title":"British Journal of General Practice"},{"key":"pcbi.1012408.ref019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/MPA.0000000000000527","article-title":"Symptoms of Pancreatic Cancer in Primary Care","volume":"45","author":"M Schmidt-Hansen","year":"2016","journal-title":"Pancreas"},{"key":"pcbi.1012408.ref020","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer.","volume":"395","author":"JD Mizrahi","year":"2020","journal-title":"The Lancet"},{"key":"pcbi.1012408.ref021","doi-asserted-by":"crossref","first-page":"e007825","DOI":"10.1136\/bmjopen-2015-007825","article-title":"Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.","volume":"5","author":"J Hippisley-Cox","year":"2015","journal-title":"BMJ Open"},{"key":"pcbi.1012408.ref022","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1038\/sj.bjc.6605396","article-title":"The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients","volume":"101","author":"W. Hamilton","year":"2009","journal-title":"British Journal of Cancer"},{"key":"pcbi.1012408.ref023","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/bjc.2015.409","article-title":"Risk prediction tools for cancer in primary care","volume":"113","author":"J Usher-Smith","year":"2015","journal-title":"British Journal of Cancer"},{"issue":"684","key":"pcbi.1012408.ref024","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.3399\/bjgp19X703745","article-title":"Availability and use of cancer decision-support tools: a cross-sectional survey of UK primary care","volume":"69","author":"S Price","year":"2019","journal-title":"Br J Gen Pract"},{"key":"pcbi.1012408.ref025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdr561","article-title":"The prognostic and predictive value of serum CA19.9 in pancreatic cancer","volume":"23","author":"JL Humphris","year":"2012","journal-title":"Annals of Oncology"},{"issue":"2","key":"pcbi.1012408.ref026","doi-asserted-by":"crossref","first-page":"188409","DOI":"10.1016\/j.bbcan.2020.188409","article-title":"Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter","volume":"1875","author":"G Luo","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Reviews on Cancer."},{"issue":"2","key":"pcbi.1012408.ref027","first-page":"105","article-title":"The clinical utility of serum CA 19\u20139 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.","volume":"3","author":"UK Ballehaninna","year":"2012","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"pcbi.1012408.ref028","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1158\/1078-0432.CCR-20-3929","article-title":"Development and Multiple Validation of the Protein Multi-marker Panel for Diagnosis of Pancreatic Cancer","volume":"27","author":"Y Kim","year":"2021","journal-title":"Clin Cancer Res"},{"key":"pcbi.1012408.ref029","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/gutjnl-2021-324739","article-title":"Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?","volume":"71","author":"TP Potjer","year":"2022","journal-title":"Gut"},{"key":"pcbi.1012408.ref030","doi-asserted-by":"crossref","first-page":"101747","DOI":"10.1016\/j.eclinm.2022.101747","article-title":"Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data","volume":"55","author":"LNC Boyd","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"10","key":"pcbi.1012408.ref031","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/2767-9764.CRC-22-0190","article-title":"Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis","volume":"2","author":"LE Kane","year":"2022","journal-title":"Cancer Res Commun"},{"key":"pcbi.1012408.ref032","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"JD Cohen","year":"2018","journal-title":"Science"},{"issue":"6","key":"pcbi.1012408.ref033","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"MC Liu","year":"2020","journal-title":"Annals of Oncology"},{"issue":"9","key":"pcbi.1012408.ref034","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"EA Klein","year":"2021","journal-title":"Annals of Oncology"},{"issue":"19","key":"pcbi.1012408.ref035","article-title":"Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial.","volume":"14","author":"RD Neal","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"10290","key":"pcbi.1012408.ref036","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.","volume":"397","author":"U Menon","year":"2021","journal-title":"Lancet"},{"key":"pcbi.1012408.ref037","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s43856-023-00237-5","article-title":"Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning.","volume":"3","author":"NR Nen\u00e9","year":"2023","journal-title":"Communications Medicine."},{"issue":"2","key":"pcbi.1012408.ref038","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41416-019-0675-3","article-title":"Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2 (PKM2).","volume":"122","author":"AD James","year":"2020","journal-title":"Br J Cancer"},{"issue":"10","key":"pcbi.1012408.ref039","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/sj.bjc.6604364","article-title":"MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer","volume":"98","author":"WR Matull","year":"2008","journal-title":"Br J Cancer"},{"issue":"25","key":"pcbi.1012408.ref040","doi-asserted-by":"crossref","first-page":"17430","DOI":"10.18632\/oncotarget.24732","article-title":"Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis.","volume":"9","author":"J Cuenco","year":"2018","journal-title":"Oncotarget"},{"key":"pcbi.1012408.ref041","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2105-14-106","article-title":"SMOTE for high-dimensional class-imbalanced data","volume":"14","author":"R Blagus","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"pcbi.1012408.ref042","article-title":"ADASYN: Adaptive synthetic sampling approach for imbalanced learning.","author":"H He","year":"2008","journal-title":"2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computational Intelligence) SP\u20141322."},{"key":"pcbi.1012408.ref043","doi-asserted-by":"crossref","DOI":"10.1109\/ICDM.2013.21","article-title":"A Comparative Analysis of Ensemble Classifiers: Case Studies in Genomics.","volume":"2013","author":"S Whalen","year":"2013","journal-title":"2013 IEEE 13th International Conference on Data Mining"},{"issue":"8","key":"pcbi.1012408.ref044","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.pan.2020.10.002","article-title":"ADEPTS (Accelerated Diagnosis of neuroEndocrine and Pancreatic TumourS) and EDRA (Early Diagnosis Research Alliance).","volume":"20","author":"S Pereira","year":"2020","journal-title":"Pancreatology"},{"issue":"3","key":"pcbi.1012408.ref045","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030364","article-title":"A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.","volume":"14","author":"MB Bestari","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"pcbi.1012408.ref046","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10565-019-09465-9","article-title":"Proteomic and genomic profiling of pancreatic cancer","volume":"35","author":"D Ansari","year":"2019","journal-title":"Cell Biol Toxicol"},{"issue":"3","key":"pcbi.1012408.ref047","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10030067","article-title":"Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges.","volume":"10","author":"A Root","year":"2018","journal-title":"Cancers (Basel)."},{"issue":"3","key":"pcbi.1012408.ref048","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/1078-0432.CCR-14-0365","article-title":"Serum CA19-9 is significantly up-regulated up to 2 years prior to diagnosis with pancreatic cancer: implications for early disease detection","volume":"21","author":"DP O\u2019Brien","year":"2015","journal-title":"Clin Cancer Res"},{"key":"pcbi.1012408.ref049","unstructured":"QCancer-2018 risk calculator for men: http:\/\/qcancer.org\/male ["},{"key":"pcbi.1012408.ref050","unstructured":"QCancer-2018 risk calculator for women: http:\/\/qcancer.org\/female ["},{"key":"pcbi.1012408.ref051","unstructured":"[Available from: https:\/\/www.nice.org.uk."},{"key":"pcbi.1012408.ref052","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers14010217","article-title":"The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy.","volume":"14","author":"N Sturm","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"pcbi.1012408.ref053","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41598-020-57930-x","article-title":"CA19-9 for detecting recurrence of pancreatic cancer","volume":"10","author":"A Azizian","year":"2020","journal-title":"Sci Rep"},{"key":"pcbi.1012408.ref054","first-page":"18","article-title":"Ensemble selection from libraries of models","author":"R Caruana","year":"2004","journal-title":"Proceedings of the twenty-first international conference on Machine learning; Banff, Alberta, Canada: Association for Computing Machinery"},{"issue":"4","key":"pcbi.1012408.ref055","doi-asserted-by":"crossref","first-page":"e1249","DOI":"10.1002\/widm.1249","article-title":"Ensemble learning: A survey","volume":"8","author":"O Sagi","year":"2018","journal-title":"WIREs Data Mining and Knowledge Discovery"},{"key":"pcbi.1012408.ref056","first-page":"2020.06.25.20140053","volume-title":"Discriminative Subtyping of Lung Cancers from Histopathology Images via Contextual Deep Learning","author":"JL Benjamin","year":"2022"},{"issue":"5","key":"pcbi.1012408.ref057","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","article-title":"A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories","volume":"29","author":"D Placido","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"pcbi.1012408.ref058","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41416-019-0718-9","article-title":"Improved early detection of ovarian cancer using longitudinal multimarker models","volume":"122","author":"HJ Whitwell","year":"2020","journal-title":"British Journal of Cancer"},{"issue":"4","key":"pcbi.1012408.ref059","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).","volume":"10","author":"U Menon","year":"2009","journal-title":"Lancet Oncol."},{"key":"pcbi.1012408.ref060","doi-asserted-by":"crossref","first-page":"a2079","DOI":"10.1136\/bmj.a2079","article-title":"Recruitment to multicentre trials\u2014lessons from UKCTOCS: descriptive study","volume":"337","author":"U Menon","year":"2008","journal-title":"Bmj"},{"key":"pcbi.1012408.ref061","unstructured":"Data normalization and standardization [Available from: https:\/\/www.olink.com\/content\/uploads\/2021\/09\/olink-data-normalization-white-paper-v2.0.pdf."},{"key":"pcbi.1012408.ref062","first-page":"2021.12.02.21267187","volume-title":"Early detection of pancreatic ductal adenocarcinomas with an ensemble learning model based on a panel of protein serum biomarkers","author":"NR Nen\u00e9","year":"2021"},{"issue":"1","key":"pcbi.1012408.ref063","first-page":"321","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"V. C Nitesh","year":"2002","journal-title":"Journal of Artificial Intelligence Research"},{"issue":"10","key":"pcbi.1012408.ref064","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1073\/pnas.102102699","article-title":"Selection bias in gene extraction on the basis of microarray gene-expression data","volume":"99","author":"C Ambroise","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pcbi.1012408.ref065","first-page":"2079","article-title":"On over-fitting in model selection and subsequent selection bias in performance evaluation","volume":"11","author":"GC Cawley","year":"2010","journal-title":"The Journal of Machine Learning Research"},{"issue":"5","key":"pcbi.1012408.ref066","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41563-018-0241-z","article-title":"Avoiding common pitfalls in machine learning omic data science","volume":"18","author":"AE Teschendorff","year":"2019","journal-title":"Nat Mater"},{"issue":"3","key":"pcbi.1012408.ref067","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41576-021-00434-9","article-title":"Navigating the pitfalls of applying machine learning in genomics","volume":"23","author":"S Whalen","year":"2022","journal-title":"Nat Rev Genet"},{"key":"pcbi.1012408.ref068","volume-title":"Machine Learning and Knowledge Discovery in Databases","author":"CA Scholbeck","year":"2020"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1012408","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T13:42:29Z","timestamp":1726062149000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012408"}},"subtitle":[],"editor":[{"given":"Rodrigo","family":"Mora","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1012408","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.24.23300505","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}